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Abstract: Current strategies for tissue engineering of bone rely on the implantation of scaffolds, colonized with human 
mesenchymal stem cells (hMSC), into a recipient. A major limitation is the lack of blood vessels. One approach to 
enhance the scaffold vascularisation is to supply the scaffolds with endothelial cells (EC). 
The main goal of this study was to establish a coculture system of hMSC and EC for the purposes of bone tissue 
engineering. Therefore, the cell behaviour, proliferation and differentiation capacity in various cell culture media as well 
as cell interactions in the cocultures were evaluated. 
The differentiation capacity of hMSC along osteogenic, chondrogenic, and adipogenic lineage was impaired in EC 
medium while in a mixed EC and hMSC media, hMSC maintained osteogenic differentiation. In order to identify and 
trace EC in the cocultures, EC were transduced with eGFP. Using time-lapse imaging, we observed that hMSC and EC 
actively migrated towards cells of their own type and formed separate clusters in long term cocultures. The scarcity of 
hMSC and EC contacts in the cocultures suggest the influence of growth factor-mediated cell interactions and points to 
the necessity of further optimization of the coculture conditions. 
Keywords: Coculture, endothelial cells, mesenchymal stem cells, differentiation, time-lapse, tissue engineering of bone. 
INTRODUCTION 
  In the field of bone tissue engineering, human 
mesenchymal stem cells (hMSC) are commonly used as 
osteoprogenitor cells for colonization of scaffolds to be 
implanted in the injured tissue [1-3]. Adult hMSC are 
defined mainly by their capacity of differentiating along 
multiple lineages into end-stage mesenchymal cell 
phenotypes [4-7]. These include bone/osteoblasts [8,9], 
cartilage/chondrocytes [10,11], fat/adipocytes [12,13] as well 
as a variety of other connective tissues such as muscle [14] 
or stroma [15]. In addition, the hMSC secrete a variety of 
cytokines and growth factors that have both paracrine and 
autocrine activities [16-19]. 
  Osteogenic and endothelial cells (EC) have been 
demonstrated to closely associate in the process of bone 
regeneration and to produce growth factors that affect the 
growth and differentiation of the reciprocal cell type [20,21]. 
This implies that presence of EC on the implanted scaffolds 
may help to achieve an optimal colonization of the tissue 
constructs. The hMSC cultured in direct contact with EC 
manifested an increased osteogenic differentiation in vitro 
[22]. In vivo, cotransplantation of EC with hMSC resulted in  
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more bone formation than did the transplantation of hMSC 
alone [23]. In contrast, only few hMSC survived when 
implanted on scaffolds into athymic nude mice [24]. 
  The combination of EC and osteoprogenitor cells is 
expected to not only accelerate the vascularization essential 
for delivery of nutrients to the developing bone but also to be 
beneficial for the growth and differentiation of both cell 
types. Osteoprogenitor cells are known to secrete VEGF and 
could therefore enhance the proliferation and differentiation 
of EC [21,25], on their turn, can enhance the proliferation 
and differentiation of osteoprogenitor cells by the secretion 
of osteogenic growth factors [26,27]. 
  The goal of this study was to examine the interactions of 
hMSC and EC in cocultures. We cultured hMSC from three 
different donors with EC and analyzed the capacity of hMSC 
to proliferate and to differentiate in growth media supporting 
the growth of both hMSC and EC. As endothelial cell model, 
we used the human endothelial cell line AS-M.5 which has 
demonstrated to manifest the characteristics of freshly 
isolated endothelial cells [28,29]. Finally, we observed both 
short and long term development of cocultures of hMSC and 
EC as well as the interactions of the two cell types.  
MATHERIALS AND METHODS 
Cell Culture 
  The hMSC from 3 different caucasian donors of 18 
(donor I), 19 (donor II), and 25 (donor III) years of age Coculture of hMSC and Endothelial Cells  The Open Biomedical Engineering Journal, 2010, Volume 4    191 
(Lonza, Basel, Switzerland) were used and expanded in 
Mesenchymal Stem Cell Growth Medium (Lonza) for one 
week before being used in the experiments. Endothelial cell 
line AS-M.5 cells [28,29] were propagated in Endothelial 
Cell Growth Medium MV (PromoCell, Heidelberg, 
Germany). This low serum (5%) medium contains no 
additional growth factor supplements like VEGF of EGF-2 
that may influence the dynamics between cell populations. 
The cells were plated at a density of 2000 cells/cm
2. The 3 
test media were M1: cell culture medium developed for 
expansion of hMSC, supplemented with FGF-2 to enhance 
their mitogenic potential [30] containing D-MEM high 
Glucose with L-Glutamine and Sodium Pyruvat, (PAA 
Laboratories, Pasching, Austria), 10 % fetal bovine serum 
(FBS), Penicilin- Streptomycin, (Sigma Aldrich, St. Louis, 
USA), and 5 ng/ml Fibroblast Growth Factor 2 (FGF-2, 
RELIATech, Braunschweig, Germany), M2: M1 and M3 
mixed in a ratio of 1:1, and M3: Endothelial Cell Growth 
Medium MV (PromoCell). Medium M2 was designed for the 
propagation of the two cell types we studied in cocultures in 
order to maintain enough factors in the medium to sustain 
the viability of both cell types without affecting/ inducing 
their differentiation. Cells were subcultured by 
trypsinization, and reseeded at a density of 2000 cells/cm
2 
after 7 and 14 days of culture. Prior testing the effects of cell 
culture medium, cells were kept in each particular medium 
for 21 days, as indicated in Fig. (1). 
Cocultures 
  For long-term experiments, cocultures were initiated by 
plating cell suspensions containing hMSC-EGFP und AS-
M.5 in equal proportion at a density of 500 cells/cm
2 in 25 
cm
2 tissue culture flasks in M2 medium. The development of 
the cultures was followed over 3 weeks, medium was 
changed twice weekly. In short-term experiments, hMSC-
EGFP and AS-M.5 were plated at a density of 3000 cells/cm 
on 35 mm cell culture dishes (BD Falcon, San Jose, USA) 
and cultured for 6, 30, and 54 h. The time-lapse pictures 
were taken at interval of 5 min for 12h using digital camera 
AxioCam MRm mounted on Axiovert S100 (Carl Zeiss).  
Induction of Differentiation and Evaluation of 
Differentiation Potential of hMSC 
  Differentiation was induced by propagating hMSC in the 
culture media containing differentiation supplements. 
Briefly, 5 x 10
3 cells/cm
2 were seeded in the maintenance 
medium (M1, M2 or M3), and cultured till 80 % confluency.  
 Osteogenic  differentiation of hMSCs was assessed using 
a well-established assay [7]. Stimulation with osteogenic 
supplements 100 nM dexamethasone, 10 mM  – 
glycerophosphate, and 50 M L-ascorbic acid-2-phosphate 
(all Sigma Aldrich) started after the cells reached confluence 
of about 80 %. Medium was changed twice weekly. 
 Chondrogenic  differentiation was induced in high density 
pellet cell cultures as previously described [7]. Briefly, 2.5 x 
10
5 cells were centrifuged (500g, 5 min, RT), the cell pellets 
were cultured in 1 ml of medium without FBS but containing 
chondrogenic supplements: 100 nM dexamethasone, 1mM 
pyruvate, 195 M L-ascorbic acid-2-phosphate, 350 M L-
proline, 1,25 % (v/v) insulin-transferrin- selenious acid mix 
(ITS, 100x), 5,35 g/ml linolic acid, 1,25 mg/ml bovine 
serum albumine (BSA) (Sigma Aldrich). Finally, TGF- 3 
(R&D Systems, Minneapolis, USA) was added to a final 
concentration of 10 ng/ml, and then incubated in a 95% 
humidified atmosphere, 5% CO2 at 37°C for 5 weeks. The 
medium was changed 2 – 3 times a week. Chondrogenic 
differentiation was assayed after 5 weeks of stimulation. 
 Adipogenic  differentiation was induced according to a 
published protocol [7]. Stimulation with adipogenic 
supplements (1 M dexamethasone, 0.2 mM indomethacin, 
0.1 mg/ml insulin, 1 mM 3-isobutyl-1-methylxanthin 
(IBMX) (Sigma Aldrich) started after the cells reached full 
confluence. After five days of growth in the adipogenic 
stimulation, medium the cultures were set in the maintenance 
medium for two days, and finally in the stimulation medium 
again. The medium was changed three times a week.  
  Cells cultured in parallel in the medium lacking 
differentiation supplements were used as negative controls. 
Detection of Differentiated Cells 
  Differentiated cells of osteogenic lineage were detected 
after 21 days of stimulation by von Kossa staining using a 
standard protocol. 
  To evaluate chondrogenesis in the aggregates, the 
cultures were harvested and subsequently frozen in Jung 
tissue freezing medium (Leica Instruments, Wetzlar, 
Germany). Twelve m sections were cut with a cryostat 
 
 
 
 
 
 
 
 
Fig. (1). Flowchart of cultivation protocols and assays. The population doubling times of hMSC were determined in media M1 (D-MEM 
high Glucose with 10 % FBS and Penicilin- Streptomycin), M2 (M1 and M3 mixed in a ratio of 1:1), and M3 (Endothelial Cell Growth 
Medium MV). The differentiation capacity of hMSC was analyzed by culturing the cells in media promoting the differentiation along 
different lineages, followed by cell type specific staining as well as by RT-PCR. AG – adipogenic supplements; CG – chondrogenic 
supplements; OG – osteogenic supplements. 192    The Open Biomedical Engineering Journal, 2010, Volume 4  Ern et al. 
vacutome  HM 500 OM (Microm, Walldorf, Germany). 
Type II collagen was detected using mouse monoclonal 
antibody CIIC1 (DSHB, University of Iowa, Iowa City, 
USA), biotinylated anti-mouse secondary antibody 
(Vectastain Elite ABC Kit Mouse IgG) in combination with 
the 3,3´-diaminobenzidine DAB Substrate Kit (both Vector 
Laboratories, Burlingame, USA) according to the 
instructions of the manufacturer.  The sections were 
counterstained in Mayer´s hemalaun.  
  Adipogenic cells were detected by oil red O staining. The 
cultures were fixed with 3,7 % formaldehyde (Merck, 
Darmstadt, Germany) for 2 minutes at -20 °C, washed with 
chilled 50 % ethanol, stained by incubation with 0,2 % (w/v) 
oil red O solution (Sigma Aldrich), and subsequently 
photographed with a Sony digital camera (DSC-S75, Sony, 
Tokyo, Japan) attached to an Axiovert S100 microscope 
(Carl Zeiss, Jena, Germany). 
Immunofluorescence Analysis 
  Cells (1 x 10
4 cells/well) were cultured on 8-well culture 
slides (BD Biosciences, San Jose, USA) for 24h, fixed with 
3.7% formaldehyde in cytoskeleton stabilizing buffer (CS: 
0.1 M PIPES, 1 mM EGTA, 4% [w/v] polyethylene glycol 
8000 (all Sigma-Aldrich), 137 mM NaCl, 5mM KCl, 1.1mM 
Na2 H 2 PO4, 0.4 mM K2 H 2 PO4, 5.5 mM glucose, 5 mM 
PIPES, 1 mM MgCl2, 2 mM EGTA (pH 6.9), [31], and 
exposed to the primary antibodies M0823 (DAKO, Glostrup 
Denmark, Germany) and 5561 (BD Biosciences) to detect 
the characteristic endothelial proteins CD31 and CD144, 
respectively. Secondary antibody was Alexa Fluor 488 anti-
mouse IgG (Molecular Probes, Leiden, The Netherlands). 
The staining was evaluated using fluorescence microscope 
Axioscope 2 and digital camera AxioCam MRm (Carl 
Zeiss). 
RNA Isolation and RT-Polymerase Chain Reaction 
(PCR) Analyses 
  Total cellular RNA was isolated using RNeasy mini kit 
(Qiagen, Hilden, Germany) and reverse-transcribed using the 
First-Strand cDNA Synthesis Kit (Invitrogen, Carlsbad, 
USA) according to the instructions of the manufacturer. The 
expression of the transcripts encoding osterix, PPAR 2, and 
human collagen II was assessed with specific primer pairs 
[32] and using PCR mix (Invitrogen). Amplifications were 
performed in a PTC-200 cycler (MJ Research, Walthem, 
USA) for 25 - 35 cycles, (typically: 95°C for 30 s, 50-55°C 
for 30 s, 72°C for 60 s after an initial denaturation at 95°C of 
3 minutes, and followed by the final extension at 72°C for 10 
minutes. To control the integrity of cDNA, the house-
keeping glyceraldehyde-3-phosphate dehydrogenase 
(GAPDH) was amplified in parallel reactions [33]. PCR 
products were analysed on 1.8% agarose gel and visualised 
by ethidium bromide staining. 
Lentiviral Vector Constructs, Lentivirus Production, and 
Transduction of Target Cells 
  The cDNA encoding the enhanced green fluorescent 
protein (EGFP) from the plasmid pEGFP-N3 (Takara Bio 
Europe /Clontech, Saint-Germain-en-Laye, France) was 
ligated into the lentiviral vector pLenti6V5-DEST 
(Invitrogen). Lentivirus was produced using the ViraPower 
lentiviral expression system (Invitrogen) according to the 
instructions of the manufacturer with minor adjustments 
[34]. Viral supernatant was used in a 1:2 dilution in normal 
growth media for transduction of 6 x 10
3 hMSCs / cm
2. The 
transduced cells were selected with 5 g/ml blasticidin S 
HCl (Invitrogen). The eGFP- transduced hMSCs were able 
to differentiate towards adipogenic, osteogenic, and 
chondrogenic lineages suggesting that they have fully 
retained their stem cell character [34]. 
RESULTS 
Development of hMSC and EC Cultures in Various 
Growth Media 
  The effects of growth medium on the proliferation and 
differentiation capacity of hMSC and EC were examined as 
indicated in the flow chart (Fig. 1). Searching for a medium 
that support the growth of both hMSC and EC in cocultures, 
we evaluated the cell growth rate of hMSC in medium M1 
(DMEM + FGF-5ng/ml), M2 (1: 1 mixture of M1 and M3), 
and M3 (endothelial cell growth medium MV). 
  Major differences in the proliferation rate of hMSC 
isolated from three different donors were observed in the 
three media tested. The cumulative population doubling of 
hMSC in the course of 21 days of cultivation have shown 
significant donor-dependent differences (Fig. 2). While 
hMSC of donor II and III (Fig. 2B, C) proliferated in M3 
more rapidly than in M1 during the first two weeks, the 
growth of hMSC of donor I was in M3 much slower than in 
the M1. The hMSC of all 3 donors proliferated in M2 either 
as fast as in the M1 or faster. Similarly, virtually no 
proliferation of EC was observed in M1 but a slow 
proliferation of EC was measured in the M2. Even though 
the cultures of hMSC isolated from 3 different donors 
proliferated continuously in the M1 in the course of the 
observation period of 21 days, they differed substantially in 
the number of population doubling they ultimately reached. 
While the cultures of donor III reached population doubling 
of 10, the cultures of the remaining donors did not surpass 7 
population doublings. The hMSC cultures isolated from 
different donors differed also in their capacity to proliferate 
in M3. While hMSC cultures from donor I and III ceased to 
proliferate exponentially in M3 after about 2 weeks in 
culture, the cultures from the donor II continued to 
proliferate in M3 at a similar rate as in the M1. 
  The hMSC cultures of all three donors tested showed 
similar cell morphology in response to the three growth 
media tested (Fig. 3). While a large proportion of hMSC 
grown in M1 manifested the typical fibroblast-like 
morphology (Fig. 3A), giant senescent cells were observed 
in the hMSC cultures propagated either in M2 (Fig. 3B) or in 
M3 (Fig. 3C). Endothelial AS.M-5 showed their typical 
morphology in M3 (Fig. 3F) whereas few morphologically 
aberrant cells were observed in M2 and M1 (Fig. 3D, E). 
Differentiation Capacity of hMSC 
  In order to evaluate the effects of growth media on the 
differentiation potential of hMSC and to prove their stem 
cell character, we propagated the hMSC of the three donors 
in the three growth media for 21 days and subsequently 
subjected the cells to treatments known to induce osteogenic, 
chondrogenic, and adipogenic differentiation. Osteogenic 
differentiation could be induced in hMSC propagated in all Coculture of hMSC and Endothelial Cells  The Open Biomedical Engineering Journal, 2010, Volume 4    193 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (2). The proliferation rate of hMSC is donor dependent. Cumulative population doublings of hMSC from 3 different donors (A, B, C) 
and AS-M.5 (D) in cultures supplemented with M1 (diamonds, full line), M3 (triangles, dashed), and M2 (squares, dashed line) in the course 
of 21 days of cultivation. Indicated are means +/- SEM. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (3). Cell culture media affect the morphology of hMSC. The hMSC (A, B, C) and AS-M.5 (D, E, F) were grown in medium M1 (A, D), 
medium M2 (B, E), and medium M3 (C, F) for 18 days. Phase contrast, bar represents 100 m.  
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Fig. (4). Growth media affect the differentiation potential of hMSC in vitro. The hMSC were grown in M1 (A, D, G), M2 (B, E, H), and M3 
(C, F, J) for 21 days, and subsequently subjected to differentiation. The osteogenic differentiation was detected by means of von Kossa 
staining (A, B, C), adipogenic differentiation by means of oil red O staining (D, E, F), and chondrogenic differentiation by means of collagen 
II staining (G, H, J). Bar represent 200 m (B), 100 m (A, C, G insert), 50 m (D, E, F), and 300 m (G, H, J). 
three media tested, as shown by means of von Kossa staining 
(Fig. 4A, B, C). In addition, the expression of the osteogenic 
differentiation marker osterix in the cells that have been 
propagated in M1, M2 or M3 was demonstrated by RT-PCR 
(Fig. 5).  
  Chondrogenic differentiation could be induced only in 
the hMSC cultures propagated in M1. The expression of 
collagen II, the marker for chondrogenic differentiation, was 
detected both by immunohistological staining (Fig. 4G) and 
by RT-PCR (Fig. 5). In contrast, no expression of collagen II 
could be detected either by immunohistological staining 
(Fig.  4H,  J) or by means of RT-PCR, in the hMCS 
propagated in either M2 or M3.  
  An accumulation of triglycerides in the cytoplasm after 
the induction of adipogenic differentiation was observed 
hMSC grown in all three media as demonstrated by oil red O 
staining (Fig. 4D, E, F). However the hMSC cultures growth 
in M2 and M3 were less dense than those grown in M1. 
Accordingly, less transcripts encoding peroxisome 
proliferator activated receptor  (PPAR-) could be detected 
in the cultures grown in M2 and M3 (Fig. 5).  
  To ensure, that the endothelial supplements included both 
in M2 and M3, do not induce endothelial differentiation of 
hMSC, we stained hMSC propagated in these media for the 
characteristic endothelial markers CD31 (PECAM-1) and 
CD144 (VE-cadherin). No CD31 or CD144 expression could 
be detected. AS-M.5 propagated in M2 preserved the 
expression of these typical endothelial cell surface marker 
molecules (data not shown). 
Cocultures of hMSC and EC 
  Close interactions between the EGFP-labeled hMSC and 
EC were observed only sporadically in the cocultures 
propagated in medium M2 for 21 days. A large majority of 
EC developed separate colonies (Fig. 6). In addition, we 
observed large relatively loose colonies of EC associated 
with few hMSC (Fig. 6, colony1), small dense EC clusters 
amidst sparsely distributed hMSC (Fig. 6, colony 2) as well 
as compact EC colonies of EC covered with few hMSC (Fig. 
6, colony 3) were discerned. The scarcity of direct contacts 
between the two cell types was obvious also after 
immunofluorescence staining of CD31-positive cells (Fig. 
7). Merging of cells of different type was sporadic. However, Coculture of hMSC and Endothelial Cells  The Open Biomedical Engineering Journal, 2010, Volume 4    195 
occasionally we observed both EC cells enclosed in a cluster 
of hMSC (Fig. 7E) and isolated hMSC enclosed in a cluster 
of EC (Fig. 7D). 
  By time-lapse imaging, we could observe both hMSC 
and EC actively migrating to join the cells of the same type 
to finally form clusters (Fig. 8). We could observe that, after 
adhesion followed by a period of active orientation of 
several hours, the cells started to migrate to join the cells of 
the same type (Fig. 8).  
DISCUSSION 
    Aiming at the establishment of cocultures of hMSC 
and EC for purposes of tissue engineering of bone, we 
systematically examined the growth characteristics of hMSC 
in medium supporting the growth of both hMSC and EC. In 
order to assess possible donor dependent variations of hMSC 
characteristics and functioning we analysed hMSC from 3 
independent donors anticipating that hMSC isolated from the 
same donor as EC would react differently in cell culture. The 
cultures of hMSC proliferated continuously reaching the 
population doubling of up to 10 in the course of the 
observation period of 21 days. The early development 
similar to that reported for the hMSC of average young 
donors having the capacity to undergo 24-40 population 
doublings [35]. However, in our experiments, the 
propagation rate of hMSC slowed down in the course of 21 
days in the coculture medium M2 (Fig. 2). Even thought the 
observation period did not exceed 21 days, we could observe 
extensive differences in the proliferation rate of hMSC 
isolated from different donors and this confirms previous 
reports [35]. 
  Independently of the differences in their growth 
potential, the hMSC from all three donors responded 
similarly to the induction toward osteogenic, chondrogenic, 
and adipogenic lineages. As demonstrated by both 
immunofluorescence and semi-quantitative RT-PCR, only 
cells propagated M1 presented the full differentiation 
potential of hMSC. The capacity to differentiate along either 
chondrogenic or osteogenic lineages was reduced in hMSC 
propagated in M2 and M3. In contrast, the multipotency of 
hMSC propagated in Ham’s F-12 medium was reported to be 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (5). Expression of characteristic differentiation marker is 
dependent on the growth medium. RT-PCR analysis of gene 
expression of hMSC cultured in the three types of growth medium 
(M1, M2, M3), and subsequently in medium inductive for 
osteogenic, adipogenic, and chondrogenic differentiation. The 
expression of marker characteristic for each lineage was assayed by 
RT-PCR. Osterix transcription factor for osteogenic, PPAR2 
transcription factor for adipogenic and collagen type II for 
chondrogenic differentiation. RNA integrity was assessed by 
GAPDH amplification. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (6). The hMSC and EC form distinct colonies in cocultures. Mixtures of EGFP-transduced hMSC and EC were propagated in the 
coculture medium for 21 days. Shown are typical clusters of endothelial cells: loose colonies associated with few hMSC (colony 1), small 
dense clusters amidst sparsely distributed hMSC (colony 2), and compact colonies covered with few hMSC (colony 3). Bar represents 100 
m. 196    The Open Biomedical Engineering Journal, 2010, Volume 4  Ern et al. 
retained up to 23 population doublings [36]. In addition, 
hMSC preserved their typical morphology for 38 population 
doublings in medium D-MEM [37]. Interestingly, osteogenic 
differentiation of hMSC was reported to be preserved despite 
apparent cell senescence and slowdown in the proliferation 
rate [36,37]. However a progressive loss of adipogenic and 
chondrogenic potential in the course of propagation was 
observed in hMSC-derived clones [38].  
  We could not detect any expression of either CD31 or 
CD144 on the surface of hMSC from 3 different donors 
cultured in M2 containing endothelial cell growth 
supplements for 21 days. Bone marrow-derived hMSC we 
used may differ in this respect from the human umbilical 
blood cord–derived hMSC reported to differentiate along an 
endothelial lineage in vitro and to acquire the capacity to 
express a variety of endothelial lineage surface markers after 
an incubation of 3 weeks in the presence of vascular 
endothelial growth factor [21], EGF, and hydrocortisone 
[39]. In addition, hMSC were demonstrated to undergo a 
medium-dependent differentiation toward EC within 5 days 
acquiring the capacity to express the endothelial VEGF- 
receptor Flk2 in coculture systems [40]. Differentiation of 
hMSC into EC and capacity to express CD31, vWF, and 
CD144 was also reported to be induced by exposure of 
hMSC to horse serum and ß-mercaptoethanol for 2 weeks 
[41]. The importance of the coculture medium components 
for the preservation of phenotypic characteristics of hMSC 
emerges also from the report on stimulation of the migration 
and invasive properties of hMSC by VEGF-A [42].  
  In our experiments, both hMSC and EC formed distinct 
clusters and the contacts between two cell types were only 
sporadic. We observed migration of cells joining the cells of 
their own type (Fig. 7). A similar re-distribution of the cells 
was previously reported in spheroids of EC and human 
osteoblasts [43]. In contrast, in cell-overloaded cocultures of 
hMSC and EC, a tight integration of hMSC into the 
endothelial monolayer involving the abolishment of the tight 
junctions was observed after only 2 hours of coculture [44]. 
A firm adhesion of hMSC to TNF- prestimulated EC was 
also observed both in flow chamber and confirmed in vivo in 
a mouse model [45]. Interestingly, hMSC, when co-
implanted with endothelial cells in a fibronectin-containing 
collagen gel, were recently found to assume the role of 
perivascular cells and this way contribute to the 
vasculogenesis process [46]. 
  Our systematic study on the development of hMSC and 
EC in coculture system shows an obvious necessity for 
further optimisation. Even though the coculture medium 
supported the proliferation of both hMSC and EC, and, in 
addition, hMSC preserved their capacity to differentiate 
along both osteogenic and adipogenic lineages, the donor-
related differences in the proliferation rate of hMSC as well 
as their constrained to differentiate along chondrogenic 
lineage in this medium should be taken into account. 
  The scarcity of close interactions of hMSC and EC in 
cocultures suggests that indirect growth factor- mediated 
rather than direct interactions may be involved in the 
reciprocal stimulation of both cell types. 
CONCLUSION 
  Aiming at the generation of vascularized bone 
replacement implants, we examined the interactions of 
hMSC and EC in cocultures. To evaluate the host-dependent 
variations, all experiment were performed with hMSC from 
3 independent donors. As endothelial cell model, we used 
the cell line AS-M.5. 
  In order to find an appropriate culture medium 
supporting an optimal growth of both cell types, we analyzed 
the capacity of hMSC to proliferate and differentiate in 3 
different growth media. These included media designed for 
either hMSC or for EC, and a medium composed of equal 
parts of both. The hMSC cultures of the three donors tested 
showed considerable differences in growth rate yet 
responded similarly to the three growth media tested. In 
addition, all hMSC responded similarly to the induction 
toward osteogenic, chondrogenic, and adipogenic lineages 
when propagated in the three growth media for 21 days and 
subsequently subjected to treatments known to induce 
osteogenic, chondrogenic, and adipogenic differentiation.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (7). Appearance of the cocultures of hMSC and EC. Mixtures 
of EGFP-transduced hMSC and AS-M.5 were cultured in M2 
medium for 21 days. CD31-positive endothelial cells were detected 
by immunofluorescence. In cocultures (A), both cell typed 
developed distinct clusters containing either endothelial cells (B) or 
hMSC (C). Close cell contact of hMSC and EC were observed only 
sporadically (D, E). Bar represent 100m (A), 20 m (B-E).  Coculture of hMSC and Endothelial Cells  The Open Biomedical Engineering Journal, 2010, Volume 4    197 
  The full differentiation capacity of hMSC was preserved 
solely in the hMSC medium. However, since all hMSC 
tested showed the capacity of osteogenic differentiation in 
the mixed medium, we used this medium in cocultures of 
hMSC and EC.  
  In order to identify and to follow up the cells in 
cocultures, we labelled EC with enhanced green fluorescent 
protein (EGFP). By time-lapse imaging over 12 h, we 
observed both hMSC and EC actively migrating to join the 
cells of their own type to form separate hMSC and EC 
clusters within 3 weeks. The scarcity of close interaction 
between hMSC and EC in cocultures suggest growth factor 
mediated cell interactions and imply the necessity of a 
careful optimalization of coculture conditions. 
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